Zydus Lifesciences Ltd (CADILAHC) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally.

Total Cash From Operating Activities Chart for Zydus Lifesciences Ltd

Zydus Lifesciences Ltd (CADILAHC) operating cash flow for FY2021 was INR 32.9B, a 31.4% change from FY2020. Zydus Lifesciences Ltd's operating cash flow grew from INR 2.3B in 2004 to INR 32.9B in 2021 (1307.9% over 17 years). Operating cash flow compound annual growth rate: 5-year CAGR of 10.6%, 10-year CAGR of 17.3%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.